Skip to content

A clinical trial to study the effects of Unani Polyherbal Formulation, in patients with Primary Dysmenorrhoea

A CLINICAL STUDY ON THE MANAGEMENT OF PRIMARY DYSMENORRHOEA (USRE TAMS IBTIDAEE) WITH A UNANI POLYHERBAL FORMULATION- AN OPEN LABEL SINGLE ARM TRIAL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077286
Enrollment
45
Registered
2024-11-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Intervention1: 1. Mur Makki (Commiphora myrrh) 2. Abhal (Juniperus communis) 3. Suddab (Ruta graveolens) 4. Majeeth (Rubia cordifolia): An Aqueous extract powder filled capsule of 625 mg of the follow

Sponsors

Ayurvedic and Unani Tibbia College Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients in age group of 14-28 years of age, Patient with VAS Score of 4 to 10, Unmarried, Patient able to participate in the study and ready to follow the instructions and signed the informed consent

Exclusion criteria

Exclusion criteria: Patient with Secondary Dysmenorrhoea, Patient having any organic Pelvic pathology (Pelvic inflammatory Disease , Uterine Fibroid, Endometriosis, Adenomyosis , Adnexal Masses , Endometrial Polyp), Patient with severe diseases (DM, IHD, HTN TB,Thyroid diseases and Renal diseases), Married, Age more than 28 years, Patient with H/O malignancy.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale (VAS) : VAS for pain intensity of Dysmenorrhoea 0-No pain ; 1-3 - Mild pain ; 4-6 - Moderate Pain ; 7-10 - Severe Pain.Timepoint: baseline , after 1st menstrual period, after 2nd menstrual period, after 3rd menstrual period

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Aysha Raza

Ayurvedic and Unani Tibbia College Hospital

draysharaza11@gmail.com9354925031

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026